April 5, 2023 April 5, 2023Diversity in FDA Clinical Trials Gets a Boost From New Legislation Clinical trials have historically fallen short of consistently and adequately representing diverse populations across therapeutic areas. On average, 75% of clinical trial participants are white, 8% […]